Atea Pharmaceuticals, Inc. (AVIR)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Atea Pharmaceuticals, Inc. (AVIR)
Go deeper and ask any question about AVIR
Company Performance
Current Price
as of Sep 13, 2024$3.87
P/E Ratio
N/A
Market Cap
$326.71M
Description
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
Metrics
Overview
- HQBoston, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerAVIR
- Price$3.87+5.45%
Trading Information
- Market Cap$326.71M
- Float87.60%
- Average Daily Volume (1m)216,328
- Average Daily Volume (3m)232,219
- EPS-$2.10
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$40.52M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$46.81M
- EV-$221.31M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset